Baden and Moriarty Take on New Roles in Research and Operations
Effective April 1, Lindsey Baden, MD, will take on a new role as vice president of Clinical Research and Allison Moriarty, MPH, will be promoted to senior vice president, Research Planning & Operations and Innovation.
As vice president of Clinical Research, Baden will provide comprehensive oversight of clinical research at the Brigham and will be responsible for developing and implementing operational strategies, as well as building and maintaining the necessary infrastructure and resources in support of our clinical research mission and operational goals. He will continue to oversee and grow the Center for Clinical Investigation, serve as the primary liaison with Harvard Catalyst/Harvard Medical School (HMS), and have responsibility for increasing and maintaining research relationships across the Brigham, our system and our local collaborators.
As senior vice president, Moriarty will take on an expanded role in research planning, operations (both research and clinical) and innovation. She will provide executive oversight of research and compliance at the Brigham including Research Operations, Research Space and Equipment Management, Sponsored Programs and Compliance, our Animal Program, Research Billing Compliance, Research Laboratory Safety, the Center for Clinical Investigation, Research Data Protection and Brigham Ignite. She will be responsible for ensuring coordination with the system-wide operating and capital budgets for key enterprise services, as well as managing the operating budget for research innovation, iHub and other innovation programs.
Fernandez-Robles Appointed Chief of Psychiatry at Brigham and Women’s Faulkner Hospital
Carlos Fernandez-Robles, MD, MBA, will become the next chief of psychiatry at Brigham and Women’s Faulkner Hospital, effective July 1, 2022. He will also serve as vice chair for BWFH in the Brigham Department of Psychiatry and as a faculty member in the Brigham and Women’s Department of Psychiatry.
Fernandez-Robles comes to BWFH from Massachusetts General Hospital where he has held several significant positions over the last few years, most recently as the clinical director of the Center for Psychiatric Oncology and Behavioral Sciences and associate director of the Somatic Therapies Service.
Fernandez-Robles is a medical graduate of the Universidad Industrial de Santander in Colombia and completed his MBA at Yale School of Management. He has also had executive education training. He completed his psychiatry training at Jackson Memorial Hospital in Miami, FL, as well as at Massachusetts General Hospital, where he was a Psychosomatic Medicine Fellow. He has extensive academic clinical experience, having held positions in Colombia, Florida, New Hampshire and Massachusetts. He is a respected clinician, leader, and educator, and is currently an assistant professor of psychiatry at Harvard Medical School. He is a fellow of the Academy of Consultation-Liaison Psychiatry, is active in the American Psychosocial Oncology Society, and is involved in diversity, equity and inclusion initiatives.
As chief of psychiatry, Fernandez-Robles will lead psychiatry services here at BWFH by partnering with BWFH’s medical, nursing and administrative leadership, as part of and in coordination with BWH’s Department of Psychiatry. He will lead the ongoing development and expansion of inpatient, partial, procedural, ambulatory and addiction programs at BWFH, as well as work continuously to improve the educational and academic programs at BWFH, an important training site.
Fernandez-Robles is specialized in the psychiatric care of patients with severe medical and psychiatric diseases. He has shown himself to be a compassionate leader who is focused on improving patient care, experience, and satisfaction through the optimization of clinical operations and the development of innovative care delivery models. We are delighted that he has chosen to advance his career as a member of Brigham and Women’s Faulkner Hospital.
Jon C. Aster, MD, PhD, has been appointed deputy chair of Pathology at the Brigham to help support, guide and advance the Mass General Brigham Enterprise Lab Service (MGBELS).
Aster, who most recently served as interim chair of Pathology, is the Michael Gimbrone Chair of Pathology at BWH and professor of Pathology at Harvard Medical School. Having spent more than 30 years at the Brigham, Aster is well-versed in all aspects of the department and has made several significant contributions as an investigator, diagnostician and educator. Best known scientifically for his work on Notch signaling in leukemia and other cancers, he also serves as the Chief of Hematopathology at the Brigham. Aster has been active in teaching on many levels, most notably as the co-editor of the Robbins Pathology textbook series.
Kayden Appointed Deputy Chair of Emergency Medicine
Kayden is an associate professor of Emergency Medicine at Harvard Medical School, the vice chair of Faculty Affairs in the Department of Emergency Medicine and the division chief of Global Emergency Care and Humanitarian Studies. Widely published in the field of global emergency care, she is an internationally known humanitarian expert, and has led field missions in several relief and development settings . She has also created a number of leadership development programs to advance the field of emergency care internationally. Kayden is known to her colleagues to be an expert clinician, dedicated educator, inspired mentor and leader of great integrity.
Giess Named Deputy Chair of Radiology
Giess joined Brigham Radiology in 2009 as a member of the Breast Imaging Division and was appointed division chief in 2016. She most recently served as the interim chair of the BWH Department of Radiology from January through September 2021. Prior to that, she served as the department’s wellness officer from 2017 to 2019, and as the senior vice chair for Physician Affairs from 2019 to 2020, overseeing division clinical operations and physician performance, as well as supervising and collaborating on initiatives in wellbeing, professional development and diversity, equity and inclusion. Giess is an associate professor of Radiology at Harvard Medical School. In that role, she focused on improving operational efficiency and decreasing workflow variability across the division.
Feldman to Serve as Co-Chair of the Ethics Committee and Associate Director of Ethics Service
Will Feldman, MD, DPhil, MPH, of the Division of Pharmacoepidemiology and Pharmacoeconomics and the Division of Pulmonary and Critical Care Medicine, has accepted the position of co-chair of the Ethics Committee and associate director of the Ethics Service, effective March 15.
Feldman has been an active member of the Brigham Ethics community since 2018. Feldman came to the Brigham for his residency in internal medicine in 2015 and completed a fellowship in pulmonary and critical care medicine. He holds a doctorate in political theory from the University of Oxford and a master’s in public health from the Harvard T.H. Chan School of Public Health. His research focuses on the pharmaceutical industry, drug pricing, health policy, bioethics and chronic obstructive pulmonary disease.
In addition to his leadership roles on the Ethics Committee and Ethics Service, Feldman will also serve as an attending physician in the Medical Intensive Care Unit, an instructor of Medicine at Harvard Medical School and a faculty member at the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics.
Feldman succeeds Nick Sadovnikoff, MD, former associate director, who recently left the Brigham after many years of dedicated service to Ethics.
Research Oversight Committee Announces Newly Elected Members
The Brigham Research Institute (BRI) Research Oversight Committee (ROC) has announced six newly elected members. The BRI is governed by the ROC, which is made up of the BRI executive committee, department chairs or their representatives, BRI center and program co-chairs, elected members and various Brigham and Mass General Brigham leaders and ad hoc members. The ROC was established to foster transparency and accountability in the decision-making process for the research enterprise and to plan new strategic initiatives; the composition of the ROC is intended to collectively reflect the diversity of the BWH research community.
The newly elected members are:
- Martin Hemberg, PhD, Basic Research
- Yohannes Tesfaigzi, PhD, Basic Research
- Amanda Lyall, PhD, Clinical Research
- Gad Marshall, MD, Clinical Research
- Naoko Sasamoto, MD, MPH, Population Science
- Alexander Turchin, MD, MS, Population Science
A full list of ROC leadership and members can be found here.